Mehr lesen
There is currently an explosive growth of basic and clinical research in inflammatory bowel diseases. The extensive interest of the medical community in these diseases is largely explained by the devastating impact the illnesses have on the quality of life, their high prevalence in the community, and the fact that so many medical disciplines are involved in tackling the immensely complex studies on pathogenesis, clinical expression and treatment possibilities.
The Falk Symposium No. 85 held in The Hague, the Netherlands, 29 June-1 July 1995 brought together over 80 speakers and 1000 participants from all over the world. Plenary sessions and workshops allowed the discussion of basic and clinical research, enabling appropriate choices to be made. Topics reflected areas of high current basic research interest, clinical importance, and actual or future treatment potential.
Audience: An important work for all disciplines involved in research and therapy of inflammatory bowel diseases.
Inhaltsverzeichnis
Preface. List of Principal Authors. An overview of the immunological basis of IBD and its therapy; J. Meenan. Plenary Session I. Workshop I: New developments in inflammation. Workshop II: Role of nitric oxide in IBD. Workshop III: Pathology of IBD revisited - a critical approach. Workshop IV: Treatment of anorectal and rectovaginal strictures and fistulas. Plenary Session II. Workshop V: Genetic make-up of IBD patient - progress in gene identification. Workshop VI: Mucosal immunology in IBD - a plea for simplification. Workshop VII: Grading of IBD activity - a plea for consensus. Plenary Session III. Workshop IX: The epithelium in IBD - two faces: barrier and immune frontier. Workshop X: What mouse models are telling us about IBD. Workshop XI: Role of mycobacteria in Crohn's disease. Workshop XII: Ileal pouch anal anastomosis - role of the transition zone. Workshop XIII: Interactions of intestinal microflora, luminal contents and the host in IBD. Workshop XIV: New IBD strategies - perspectives of anticytokine strategies. Workshop XV: Growth and development in pediatric IBD. Workshop XVI: Topically active corticosteroids. Cancer screening in IBD - Pro and Con. Index.
Zusammenfassung
There is currently an explosive growth of basic and clinical research in inflammatory bowel diseases.
